Wave Life Sciences has taken a step toward validating a new modality, becoming the first group to report therapeutic RNA editing in humans. The update on the GSK-partnered prospect sent Wave’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback